monoclonal antibodies
Showing 1 - 25 of 7,894
Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment
Recruiting
- COVID-19 Convalescent Plasma Treatment
-
Strasbourg, FranceService des Maladies Infectieuses et Tropicales - CHU de Strasbo
Jun 15, 2023
Medicare Anti-Aß mAb Coverage With Evidence Development Study
Recruiting
- Mild Alzheimer's Disease
- Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
- Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease
-
Baltimore, MarylandCenters for Medicare and Medicaid Services
Sep 21, 2023
Clostridium Infection Trial in Paris (Collection of peripheral blood mononuclear cells)
Completed
- Clostridium Infection
- Collection of peripheral blood mononuclear cells
-
Paris, FranceMaladies infectieuses et tropicales, Hôpital Pitié-Salpêtrière
Oct 3, 2022
HIV Trial in South Africa (VRC01.23LS, PGT121.414.LS, PGDM1400LS)
Not yet recruiting
- HIV Infections
- VRC01.23LS
- +2 more
-
Cape Town, Western Cape, South Africa
- +7 more
Jul 24, 2023
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies
Recruiting
- Immunocompromised Patients
- Data collection
-
Paris, Ile De France, FranceAssistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
Jul 5, 2022
Headache, Migraine Trial in Chicago, Naperville (Ubrogepant 50 MG [Ubrelvy], Ubrogepant 100 MG [Ubrelvy])
Not yet recruiting
- Headache, Migraine
- Ubrogepant 50 MG [Ubrelvy]
- Ubrogepant 100 MG [Ubrelvy]
-
Chicago, Illinois
- +1 more
Aug 14, 2022
Against BK Virus Infection Based on Monoclonal Antibodies
Not yet recruiting
- BK Virus Infection
-
Strasbourg, FranceService de Virologie - CHU Strasbourg - France
Feb 21, 2022
Allergic Rhinitis, Conjunctivitis Trial (REGN5713, REGN5714, REGN5715)
Not yet recruiting
- Allergic Rhinitis
- Conjunctivitis
- REGN5713
- +3 more
- (no location specified)
Jun 20, 2022
Long COVID, Post-Acute Sequela of COVID-19, Post-Acute COVID-19 Trial in San Francisco (AER002, Placebo)
Not yet recruiting
- Long COVID
- +2 more
- AER002
- Placebo
-
San Francisco, CaliforniaUCSF/Zuckerberg San Francisco General Hospital
Jun 2, 2023
Non Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer Trial in Huntersville (FT536, Cyclophosphamide, Fludarabine)
Recruiting
- Non Small Cell Lung Cancer
- +6 more
- FT536
- +10 more
-
Scottsdale, Arizona
- +4 more
Dec 27, 2022
Metastatic Colorectal Carcinoma Trial (Pentoxifylline, FOLFOX, XELOX)
Not yet recruiting
- Metastatic Colorectal Carcinoma
- Pentoxifylline
- +3 more
- (no location specified)
Nov 1, 2023
Neuroblastoma, Ganglioneuroblastoma Trial in Moscow (monoclonal antibodies GD2)
Recruiting
- Neuroblastoma
- Ganglioneuroblastoma
- monoclonal antibodies GD2
-
Moscow, Russian FederationResearch Institute of Pediatric Hematology, Oncology and Immunol
Oct 4, 2023
Coronavirus Infections Trial in Moscow (tixagevimab/cilgavimab 150+150 mg, tixagevimab/cilgavimab 300+300 mg, regdanvimab)
Active, not recruiting
- Coronavirus Infections
- tixagevimab/cilgavimab 150+150 mg
- +2 more
-
Moscow, Russian FederationMoscow City Clinical Hospital 52
Aug 7, 2023
Acquiring Convalescent Specimens for COVID-19 Antibodies
Completed
- COVID-19
- +2 more
- Blood draw
-
New York, New YorkColumbia University Irving Medical Center/NYP
Jul 18, 2022
COVID-19 Trial in Hong Kong (BRII-196 and BRII-198, Placebo)
Withdrawn
- COVID-19
- BRII-196 and BRII-198
- Placebo
-
Hong Kong, ChinaInvestigative Site 1
Mar 1, 2022
Monoclonal Antibodies (Sotrovimab )
Recruiting
- COVID-19 Respiratory Infection
-
Dubai, United Arab EmiratesEmirats Health Service
Dec 13, 2021
COVID-19 Trial in Beijing (BRII-196 and BRII-198, Placebo)
Completed
- COVID-19
- BRII-196 and BRII-198
- Placebo
-
Beijing, Beijing, ChinaInvestigative Site
Mar 1, 2022
SURvival of SEzary Syndrome Over 1998-2020 Period and Its
Not yet recruiting
- Sezary Syndrome
- Cutaneous T Lymphoma
- Standard of care
-
Paris, FranceHôpital Saint-Louis, Service de Dermatologie
Jan 24, 2022
Covid19 Trial in Edinburg, Rio Grande City (BAMLANIVIMAB, CASIRIVIMAB, IMDEVIMAB)
Recruiting
- Covid19
- BAMLANIVIMAB
- +2 more
-
Edinburg, Texas
- +2 more
Mar 14, 2022